This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2020.
Company Filing History:
1 out of 834,411 Years Active: 2020
Title: Edward Chouchani: Innovator in Succinate Dehydrogenase Inhibitors
Introduction
Edward Chouchani is a prominent inventor based in Cambridge, GB. He is known for his significant contributions to the field of biochemistry, particularly in the development of succinate dehydrogenase inhibitors. His work has implications for the treatment and prevention of reperfusion injuries, such as ischemia-reperfusion injury.
Latest Patents
Chouchani holds a patent for succinate dehydrogenase inhibitors (SDHi's). This invention relates to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of reperfusion injury. The invention focuses on inhibiting the accumulation of succinate, wherein the inhibitor or prodrug is a cell-permeable reversible inhibitor of succinate dehydrogenase. He has 1 patent to his name.
Career Highlights
Throughout his career, Edward Chouchani has worked at the University of Cambridge, where he has been involved in groundbreaking research. His work has garnered attention in the scientific community for its innovative approach to addressing critical health issues.
Collaborations
Chouchani has collaborated with notable colleagues, including Kourosh Saeb-Parsy and Michael Patrick Murphy. These collaborations have furthered his research and contributed to advancements in the field.
Conclusion
Edward Chouchani's contributions to the development of succinate dehydrogenase inhibitors highlight his role as an innovator in biochemistry. His work continues to influence the treatment of reperfusion injuries, showcasing the importance of innovation in medical research.